OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 02, 2014
Industry experts discuss how extractables and leachables studies are designed using a risk-based approach.
Data integrity in the analytical laboratory is an area of increasing focus for regulators such as FDA.
The CMO industry's value proposition is limiting its market penetration.
Biopharma companies should not overlook India's growing market.
April 02, 2014
The international pharmaceutical industry is changing its approach to R&D and is increasingly relying on outsourcing for drug discovery.
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
March 02, 2014
Changes in company ownership shake up the CMO industry.
February 18, 2014
Thirteen companies are accepted for participation in the supply chain program.
February 02, 2014
CMOs may find opportunities in alternative expression services.
February 01, 2014
Contract manufacturing organizations that are established in key markets can provide a competitive edge.